Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.

Neurol Neuroimmunol Neuroinflamm · 2021 · PMC7862094 · PMID 33408167

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Ocrelizumab induced a decrease in naive and memory B-cell numbers (both p < 0.0001, figure 1A and table e-1) and of plasmablasts although the last one did not reach statistical significance ( p = 0.06, figure 1A and table e-1).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.